Sponsor:
Duke University
Code:
NCT07136428
Conditions
HER2+ Metastatic Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Asciminib and Trastuzumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-08. This information was provided to ClinicalTrials.gov by Duke University on 2026-07-22.